Imaging of Vitreous Opacities in a Canadian Population

PulseMedica

Status: Not yet enrolling

Conditions: Vitreous Opacities; Floaters

Treatments: Device: SVO-ID

Study type: Interventional

Funder types: Industry

Identifiers

NCT06204848

SVO-IDFIH002

Details and patient eligibility

About

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Enrollment: 125 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Aged 18 years or older
• Symptomatic vitreous opacities (floaters) in vision
• Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

Exclusion criteria

• Younger than 18 years of age
• Presence of vitreous hemorrhage
• Cataract Grade 3 and above
• Opacification of lens, cornea, or vitreous
• Diagnosis of narrow angle glaucoma
• Refractive error is outside the range of -6D to+3D
• Astigmatism is outside the range of +/-2D of cylinder

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

125 participants in 1 patient group

Imaging using the SVO-ID

Experimental group

Description:

Patients will have their eyes imaged with the SVO-ID as part of a study visit.

Treatment:

Device: SVO-ID